ATE445160T1 - Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon - Google Patents

Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon

Info

Publication number
ATE445160T1
ATE445160T1 AT02757275T AT02757275T ATE445160T1 AT E445160 T1 ATE445160 T1 AT E445160T1 AT 02757275 T AT02757275 T AT 02757275T AT 02757275 T AT02757275 T AT 02757275T AT E445160 T1 ATE445160 T1 AT E445160T1
Authority
AT
Austria
Prior art keywords
stroke
markers
methods
diagnosis
patient
Prior art date
Application number
AT02757275T
Other languages
English (en)
Inventor
Gunars Valkirs
Jeffrey Dahlen
Kenneth Buechler
Howard Kirchick
Original Assignee
Biosite Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Inc filed Critical Biosite Inc
Application granted granted Critical
Publication of ATE445160T1 publication Critical patent/ATE445160T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AT02757275T 2001-08-20 2002-08-20 Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon ATE445160T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31377501P 2001-08-20 2001-08-20
US33496401P 2001-11-30 2001-11-30
US34648502P 2002-01-02 2002-01-02
PCT/US2002/026604 WO2003016910A1 (en) 2001-08-20 2002-08-20 Diagnostic markers of stroke and cerebral injury and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE445160T1 true ATE445160T1 (de) 2009-10-15

Family

ID=27405676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02757275T ATE445160T1 (de) 2001-08-20 2002-08-20 Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon

Country Status (7)

Country Link
US (1) US7427490B2 (de)
EP (1) EP1419388B1 (de)
JP (1) JP2005522669A (de)
AT (1) ATE445160T1 (de)
CA (1) CA2457775A1 (de)
DE (1) DE60233949D1 (de)
WO (1) WO2003016910A1 (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991907B1 (en) * 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US6627404B1 (en) * 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US6780606B1 (en) * 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
US7927784B2 (en) 2000-12-20 2011-04-19 Ev3 Vascular lumen debulking catheters and methods
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7524635B2 (en) 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030040660A1 (en) * 2001-08-27 2003-02-27 George Jackowski Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
WO2004059293A2 (en) * 2002-12-24 2004-07-15 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2005037286A1 (en) * 2003-03-25 2005-04-28 Vasopharm Biotech Gmbh Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
JP2006527190A (ja) * 2003-04-17 2006-11-30 サイファージェン バイオシステムズ インコーポレイテッド ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
GB2404981A (en) * 2003-08-15 2005-02-16 Univ Geneve Diagnostic method for stroke
EP2341350B1 (de) * 2003-09-20 2017-11-08 Electrophoretics Limited Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden basierend auf dj-1
EP1519194A1 (de) * 2003-09-24 2005-03-30 Roche Diagnostics GmbH Die Verwendung von GFAP zur Identifizierung einer Intrazerebralblutung
CA2537668A1 (en) * 2003-09-29 2005-04-14 Biosite Incorporated Methods and compositions for the diagnosis of sepsis
CN1316037C (zh) * 2003-12-19 2007-05-16 叶尚勉 检测待测标本中生存素表达量的诊断试剂、检测方法及应用
EP1562046A1 (de) * 2004-02-03 2005-08-10 B.R.A.H.M.S Aktiengesellschaft Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US7300494B2 (en) * 2005-02-24 2007-11-27 Hamilton Sundstrand Corporation On-board inert gas generation system with compressor surge protection
US7794413B2 (en) 2005-04-19 2010-09-14 Ev3, Inc. Libraries and data structures of materials removed by debulking catheters
US20070099239A1 (en) * 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
US20070038173A1 (en) * 2005-07-27 2007-02-15 Fox Hollow Technologies, Inc. Methods affecting markers in patients having vascular disease
EP1929295A4 (de) * 2005-08-30 2010-03-17 Biosite Inc Verwendung von löslichem flt-1 und seiner fragmente bei herz-kreislauf-leiden
US7807378B2 (en) * 2005-12-29 2010-10-05 Industrial Technology Research Institute (Itri) Method of diagnosing myasthenia gravis and kits therefor
US7989207B2 (en) 2006-02-17 2011-08-02 Tyco Healthcare Group Lp Testing lumenectomy samples for markers of non-vascular diseases
EP2005168A4 (de) * 2006-03-09 2009-05-20 Biosite Inc Verfahren und zusammensetzung zur diagnose von krankheiten der aorta
US20080118924A1 (en) * 2006-05-26 2008-05-22 Buechler Kenneth F Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
US20100086481A1 (en) * 2006-07-11 2010-04-08 Baird Alison E Differential expression of molecules associated with intra-cerebral hemorrhage
US7842472B2 (en) 2006-11-14 2010-11-30 Alere International Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
WO2008061149A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for diagnosis and prognosis of renal artery stenosis
SE532103C2 (sv) 2006-12-12 2009-10-27 Knut Johansen Metod för att bestämma hälsostatus från analyter i vätskeprover
US8221995B2 (en) 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
EP2152907A1 (de) 2007-05-01 2010-02-17 The Regents of the University of California Verfahren zur diagnose von ischämie
JP5339227B2 (ja) 2007-05-18 2013-11-13 国立大学法人 千葉大学 アクロレイン、インターロイキン−６及びｃｒｐの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法
KR100956764B1 (ko) * 2007-11-27 2010-05-12 한국 한의학 연구원 헤모글로빈-알파 서브유닛을 바이오 마커로 이용한 뇌졸중진단방법
WO2009075863A2 (en) * 2007-12-11 2009-06-18 New York University School Of Medicine Method for diagnosing stroke
WO2009091581A2 (en) * 2008-01-18 2009-07-23 Vatrix Medical, Inc. Diagnostic biomarkers for vascular aneurysm
KR101110758B1 (ko) 2008-06-02 2012-02-15 경북대학교 산학협력단 뇌졸중 표적용 펩티드 및 이의 용도
NO2324360T3 (de) * 2008-08-11 2018-06-30
EP2331964A1 (de) * 2008-08-13 2011-06-15 Roche Diagnostics GmbH D-dimer, troponin, nt-probnp bei lungenembolie
EP2356450B1 (de) * 2008-10-24 2019-02-06 B.R.A.H.M.S GmbH Prognose und risikobeurteilung bei schlaganfallpatienten mittels bestimmung der konzentration von markerpeptiden
JP5589000B2 (ja) * 2009-01-30 2014-09-10 バイオ−ラッド・イノヴァシオン 脳卒中のｉｎｖｉｔｒｏ診断方法
WO2010096331A1 (en) 2009-02-11 2010-08-26 Duke University Sensors incorporating antibodies and methods of making and using the same
CN101825627B (zh) * 2009-03-02 2013-10-02 江苏迈迪基因生物科技有限公司 心力衰竭的生物标志物的联合并行检测方法及诊断试剂盒
JP5747370B2 (ja) 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
US9046532B2 (en) * 2009-04-14 2015-06-02 B.R.A.H.M.S Gmbh Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
US20100312139A1 (en) * 2009-06-04 2010-12-09 Board Of Regents Of The University Of Texas System Method for Identifying Mammals at Risk for Elevated intracranial Pressure
WO2010148391A2 (en) * 2009-06-19 2010-12-23 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
JP5795256B2 (ja) * 2009-07-31 2015-10-14 バイオ−ラッド・イノベーションズＢｉｏ−Ｒａｄ Ｉｎｎｏｖａｔｉｏｎｓ 卒中のインビトロ診断のための方法
CN102576019B (zh) * 2009-08-07 2015-06-17 亲和标记技术公司 免疫鉴定脑脊液的装置和方法
ES2687469T3 (es) 2009-09-14 2018-10-25 Banyan Biomarkers, Inc. Marcadores autoanticuerpos para el diagnóstico de traumatismo craneoencefálico
CA2780301A1 (en) * 2009-11-13 2011-05-19 Bg Medicine, Inc. Risk factors and prediction of myocardial infarction
EP2504466B1 (de) 2009-11-23 2019-11-20 Proxim Diagnostics Corporation Gesteuerte elektrochemische aktivierung von elektroden auf kohlenstoffbasis
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
US8841084B2 (en) * 2010-05-14 2014-09-23 The University Of Connecticut Methods for the detection and monitoring of acute myocardial infarction
WO2011160096A2 (en) * 2010-06-17 2011-12-22 Banyan Biomarkers, Inc. Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition
CA2804763C (en) * 2010-07-14 2023-01-03 The Regents Of The University Of California Biomarkers for diagnosis of transient ischemic attacks
CA2804802C (en) 2010-07-15 2023-03-07 The Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
WO2012051519A2 (en) * 2010-10-14 2012-04-19 The Johns Hopkins University Biomarkers of brain injury
WO2012121978A2 (en) 2011-03-04 2012-09-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
WO2012155134A2 (en) 2011-05-12 2012-11-15 The Johns Hopkins University Assay reagents for a neurogranin diagnostic kit
JP5833755B2 (ja) 2011-07-25 2015-12-16 ブリマン、ミカイル 診断試験用カートリッジ
CA2850366A1 (en) * 2011-09-30 2013-04-04 The Research Institute At Nationwide Children's Hospital Compositions and methods for detection of defensins in a patient sample
CN105785053B (zh) 2011-10-17 2018-09-21 霍夫曼-拉罗奇有限公司 风险患者和中风原因的基于肌钙蛋白和bnp的诊断
EP2786154B1 (de) 2011-12-01 2017-11-01 Roche Diagnostics GmbH Nt-pro-anp und nt-pro-bnp zur diagnose eines schlaganfalls
GB2497138A (en) * 2011-12-02 2013-06-05 Randox Lab Ltd Biomarkers for stroke and stroke subtype diagnosis.
CN103163295B (zh) * 2011-12-08 2015-11-18 吴宗贵 一种用于急性冠脉综合征的液相芯片试剂盒以其制备方法
WO2013103781A1 (en) * 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
JP2015507205A (ja) * 2012-02-12 2015-03-05 ビージー メディシン，インコーポレイテッド 有害事象のリスク因子および予測
CN103308673B (zh) * 2012-03-08 2017-05-31 思芬构技术有限公司 用于预测雌性对象中发生心血管事件的风险的方法
JP6392202B2 (ja) 2012-03-13 2018-09-19 ザ・ジョンズ・ホプキンス・ユニバーシティ 脳損傷または神経変性のバイオマーカーとしてのシトルリン化脳および神経タンパク質
WO2014110674A1 (en) * 2013-01-15 2014-07-24 University Of Manitoba Biomarkers for rapid detection of an occurrence of a stroke event
GB201309928D0 (en) * 2013-06-04 2013-07-17 Randox Lab Ltd Method
WO2015009907A1 (en) 2013-07-17 2015-01-22 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
EP3032256B1 (de) * 2013-08-05 2018-11-21 Daiichi Sankyo Company, Limited Verfahren zum untersuchen von leberschadentypen
WO2015187227A2 (en) 2014-03-13 2015-12-10 Duke University Electronic platform for sensing and control of electrochemical reactions
EP3029466A1 (de) * 2014-12-03 2016-06-08 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Verfahren zur Unterscheidung eines ischämischen Schlaganfalls von einem hämorrhagischem Schlaganfall
US11078298B2 (en) 2016-10-28 2021-08-03 Banyan Biomarkers, Inc. Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
GB201619823D0 (en) 2016-11-23 2017-01-04 Randox Laboratories Ltd And Teoranta Randox GFAP accumulating stroke
CN110709704B (zh) * 2017-05-30 2024-06-21 雅培实验室 利用心肌肌钙蛋白i辅助诊断和评估人类受试者的轻度创伤性脑损伤的方法
US11685951B2 (en) 2017-07-18 2023-06-27 The Research Foundation For The State University Of New York Biomarkers for intracranial aneurysm
CN107368708B (zh) * 2017-08-14 2018-03-16 东莞博奥木华基因科技有限公司 一种精准分析dmd基因结构变异断点的方法及系统
EP3710836A4 (de) * 2017-11-16 2021-10-27 Brainbox Solutions, Inc. Proteinbiomarkerindikatoren für neurologische verletzungen und/oder erkrankung und verfahren zur verwendung davon
WO2019115620A1 (en) * 2017-12-13 2019-06-20 Roche Diagnostics Gmbh Circulating angiopoietin-2 (ang-2) and insulin-like growth factor-binding protein 7 (igfbp7) for the prediction of stroke
WO2020053881A1 (en) * 2018-09-10 2020-03-19 Indian Institute Of Technology Bombay A device to detect stroke
US11181538B2 (en) 2019-12-23 2021-11-23 Hemopet Oxidative stress biomarkers testing in canines
US11406681B2 (en) 2019-12-23 2022-08-09 Hemopet Compound for treating oxidative stress in mammals
US11596663B2 (en) 2019-12-23 2023-03-07 Hemopet Compound for treating oxidative stress in canines
US10989717B1 (en) * 2019-12-23 2021-04-27 Hemopet Oxidative stress biomarkers testing in animals
KR102332569B1 (ko) * 2020-03-05 2022-01-04 서울대학교병원 심정지 후 예후에 관한 정보를 제공하기 위한 방법, 시스템 및 비일시성의 컴퓨터 판독 가능한 기록 매체
ES2922403B2 (es) * 2021-03-03 2023-12-11 Fundacion Para La Investigacion Biomedica Del Hospital Univ La Paz Fibhulp Biomarcadores para el pronóstico de pacientes que han sufrido una hemorragia subaracnoidea aneurismática (SAH)

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447545A (en) 1980-11-03 1984-05-08 New England Deaconess Hospital Bladder cancer detection
US5350842A (en) 1986-09-30 1994-09-27 Board Of Regents, The University Of Texas System DNAs encoding Treponema pallidum antigens
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5422393A (en) 1988-07-11 1995-06-06 Naturon Pharmaceutical Corporation Natriuretic hormone
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
WO1990010870A1 (en) 1989-03-01 1990-09-20 Cornell Research Foundation, Inc. Development of a monoclonal antibody based detection system for listeria monocytogenes
WO1991000292A1 (en) 1989-06-23 1991-01-10 Genentech, Inc. Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
CA2027434C (en) 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
JPH06506688A (ja) 1991-04-10 1994-07-28 バイオサイト・ダイアグノスティックス・インコーポレイテッド クロストークインヒビターおよびその使用
EP0579767B1 (de) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5482935A (en) 1993-01-05 1996-01-09 American Home Product Corporation Anti-atherosclerotic use of 17 alpha-dihydroequilin
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6538121B1 (en) 1994-11-01 2003-03-25 Human Genome Sciences, Inc. Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
SG63691A1 (en) * 1996-02-09 1999-03-30 Nippon Kayaku Kk Epoxy resin epoxy resin composition and hardened product thereof
JP4049816B2 (ja) 1996-03-04 2008-02-20 サイオス インコーポレイテッド ｈＢＮＰ定量のためのアッセイおよび試薬
US5645995A (en) 1996-04-12 1997-07-08 Baylor College Of Medicine Methods for diagnosing an increased risk for breast or ovarian cancer
US5690103A (en) 1996-06-20 1997-11-25 Groth; Torgny Lars Detection/exclusion of acute myocardial infarction using neural network analysis of measurements of biochemical markers
JP2000500879A (ja) 1996-09-20 2000-01-25 アセロジエニクス・インコーポレイテツド 炎症性疾患の診断及びメディエータ
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6037098A (en) 1997-03-31 2000-03-14 Fuji Photo Film Co., Ltd. Positive photosensitive composition
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
ATE315228T1 (de) 1997-09-11 2006-02-15 Shionogi & Co Immunoassay zum bestimmen von bnp
AU9603398A (en) * 1997-10-07 1999-04-27 Centocor Inc. Diagnosis of thrombotic events by detecting p-selectin
US6099469A (en) 1998-06-02 2000-08-08 Armstrong; E. Glenn Reflex algorithm for early and cost effective diagnosis of myocardial infractions suitable for automated diagnostic platforms
US6117644A (en) 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
WO2000018801A2 (en) 1998-09-29 2000-04-06 Roenn Lars Christian B Ncam binding compounds
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
AT407580B (de) 1999-08-20 2001-04-25 Biomedica Gmbh Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
US6268223B1 (en) * 1999-08-27 2001-07-31 Viatech Imagin, Llc Assay for detecting damage to the central nervous system
US7054253B1 (en) 1999-09-02 2006-05-30 Asahi Glass Company, Limited Optical head
GB9929140D0 (en) 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
US6443889B1 (en) 2000-02-10 2002-09-03 Torgny Groth Provision of decision support for acute myocardial infarction
EP1297125A2 (de) 2000-06-08 2003-04-02 Chiron Corporation Zusammensetzungen und verfahren zur behandlung von neoplastischen erkrankungen mittels laminin5beta3-inhibitoren
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
US6670138B2 (en) * 2000-11-01 2003-12-30 Agy Therapeutics, Inc. Method of diagnosing ischemic stroke via UCP-2 detection
AU2002232518A1 (en) 2000-11-13 2002-05-21 Sigma-Aldrich Co. Improved assay and reagents or immunological determination of analyte concentration
US20040072805A1 (en) 2001-04-06 2004-04-15 Warren Marshelle S. Use of tumor necrosis factor inhibitors to treat cardiovascular disease
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
WO2002089657A2 (en) 2001-05-04 2002-11-14 Biosite, Inc. Diagnostic markers of acute coronary syndromes and methods of use thereof
ES2291477T3 (es) 2001-06-27 2008-03-01 Smithkline Beecham Corporation Fluoropirrolidinas como inhibidores de dipeptidil peptidasa.
JP4300108B2 (ja) 2001-06-27 2009-07-22 スミスクライン ビーチャム コーポレーション ジペプチジルペプチダーゼ阻害剤としてのピロリジン類
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
AUPS169202A0 (en) 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
US20050181386A1 (en) 2003-09-23 2005-08-18 Cornelius Diamond Diagnostic markers of cardiovascular illness and methods of use thereof

Also Published As

Publication number Publication date
EP1419388A4 (de) 2006-02-15
JP2005522669A (ja) 2005-07-28
EP1419388B1 (de) 2009-10-07
US7427490B2 (en) 2008-09-23
DE60233949D1 (de) 2009-11-19
EP1419388A1 (de) 2004-05-19
US20030119064A1 (en) 2003-06-26
WO2003016910A1 (en) 2003-02-27
CA2457775A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
ATE445160T1 (de) Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
WO2006036220A3 (en) Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
WO2002089657A3 (en) Diagnostic markers of acute coronary syndromes and methods of use thereof
US20160341742A1 (en) Methods and materials for monitoring myeloma using quantitative mass spectrometry
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
BRPI0720035A2 (pt) métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit
DE602006007703D1 (de) Verbesserte immuntestverfahren
EP1895302A3 (de) Verfahren zum Nachweis von kolorektalem Krebs in menschlichen Proben
DE69115926D1 (de) Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
WO2007080597A3 (en) Polynucleotide and polypeptide sequences and methods for diagnosis
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
DE60332538D1 (de) Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
Sahai-Srivastava et al. Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
BRPI0412110A (pt) genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos
RU2012121096A (ru) Биомаркер меланомы
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
JPWO2010004962A1 (ja) 線維筋痛症の検査法
WO2006113210A3 (en) Diagnostic multimarker serological profiling
EP1159614A4 (de) Diagnostisches verfahren für asthma
WO2004040312A3 (fr) Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie
WO2022241292A3 (en) Use of markers in the diagnosis and treatment of parkinson's disease
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties